Published on: July 23, 2016
by Ritwik Roy for International Business Times:
Scientists have designed a new protein that will help them understand why nerve cells die in those with the degenerative Alzheimer’s disease and even help in finding an Alzheimer’s cure. The University of Sussex scientists created the protein that closely resembles Amyloid-beta (Abeta) proteins in shape and size. The new protein contains two different amino acids (building blocks proteins are made of).
Abeta proteins in Alzheimer’s patients stick together to make amyloid fibrils. These in turn form clumps between neurons in the brain. Scientists believe that the build-up of these clumps causes brain cells to die. This leads to cognitive decline in Alzheimer’s patients.
Up to now, experts have not been able to know why the stickiness causes brain cells to die. They are also not sure if the Abeta protein sticky clumps have different effects compared to the individual proteins that don’t stick together.
According to the new study published in the journal Nature Scientific Reports, the new protein does not form sticky clumps or amyloid fibres. Unlike Abeta, it is not toxic to nerve cells. Understanding why and how Abeta causes nerve cell death in Alzheimer’s patients is important in finding a cure for the degenerative disease.
“Our study clearly shows that the aggregation of Abeta into bigger species is critical in its ability to kill cells. Stopping the protein aggregating in people with Alzheimer’s could slow down the progression symptoms of the disease. We hope to work towards finding a strategy to do this in the lab and reverse the damaging effects of toxic Abeta,” Study lead Dr. Karen Marshall said in a statement.
The new protein will be a significant laboratory tool for scientists who want to study the causes and role Abeta plays in Alzheimer’s disease. Senior author of the study and co-director of the University of Sussex’s Dementia Research Group, professor Louise Serpell, described the new research as exciting and “that will contribute to research to uncover the causes for Alzheimer’s disease and enable tangible progress to be made towards finding targets for therapy.”
This new laboratory tool may be made available to the Alzheimer’s research community in the near future.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.